USPTO serial 90747767
MICROBOT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- LUEKEN, ABIGAIL JOSEPHINE
- Law office
- TMEG LAW OFFICE 109 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MICROBOT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Ben Natter
Ben Natter HAUG PARTNERS, LLP745 Fifth AvenueNEW YORK, NY 10151UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | A robotic medical system consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for automated endoluminal procedures; A robotic medical system consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for advancing and navigating of medical instruments in endoluminal medical procedures; A robotic medical system consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for advancement, navigation and placement of guidewires and/or catheters in endoluminal medical procedures; A robotic medical system consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for advancement, navigation and placement of guidewires and/or catheters in endovascular procedures, namely, coronary, peripheral and cerebral endovascular procedures, gastro-intestinal procedures, urinary tract procedures, respiratory tract procedures and vaginal procedures; A robotic medical system consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for advancement, navigation and placement of guidewires and/or catheters in venous procedures; A robotic medical system consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for advancement, navigation and placement of guidewires and/or catheters in lymphatic systems; Robotically controlled drive mechanism consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for use in endoluminal medical procedures; A medical device, namely, a remote manipulation system consisting of a robotic device, namely medical device, communication means, data storage, controller and including an interface for medical instruments to facilitate remote advancement, navigation and placement of medical instruments in endoluminal medical procedures; A medical device, namely, a tele-robotic system consisting of a motorized advancement and navigation device having rotational and translational movement capabilities to facilitate remote advancement, navigation and placement of medical instruments, namely, guidewires and/or catheters and/or embolic materials, namely, coils, beads, glue; A medical device, namely, a tele-robotic system consisting of a motorized advancement and navigation device having distal end manipulation capabilities to facilitate remote manipulation of medical instruments, namely, guidewires and/or catheters, including deployment, deflection, stiffness change; A robotic image-guided medical system consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for advancement, navigation and placement of medical instruments in endoluminal medical procedures; Bedside robotic medical system consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for advancement, navigation and placement of medical instruments in endoluminal medical procedures; Body-mountable robotic medical system; Body-mountable robotic medical system consisting of a medical device, communication means, data storage, controller and including an interface for medical instruments for advancement, navigation and placement of medical instruments in endoluminal medical procedures; Guidewires for medical use; Guidewires for use in interventional cardiology, radiology, neurology and vascular surgical procedures; Guidewires having selectively adjustable stiffness, for medical use; Guidewires having selectively adjustable tip curvature, for medical use; Guidewires having telescoping arrangement, for medical use; Guidewires for use in the cardiovascular system; Guidewires having maneuverability in the cardiovascular system; Guidewire systems consisting of tubing and positioners having a tip for penetrating a lesion in coronary vessels; Double concentric guidewires for use in interventional cardiology, radiology, neurology and vascular surgical procedures; Self-cleaning catheter systems consisting of tubing and positioners for fluid delivery, drainage, and passage, for medical use; Self-cleaning catheter systems consisting of tubing and positioners for fluid delivery, drainage, and passage for use in body cavities; Implantable catheters, shunts, and delivery ports, for use in fluid delivery, drainage, and passage; Implantable catheters, namely, ventricular catheters for draining cerebrospinal fluid (CSF); External ventricular drainage (EVD) catheters; Urinary catheters; Delivery ports for medical use, namely, for chemotherapy; Implantable, self-cleaning catheter systems consisting of tubing and positioners for self-activation on receipt of a signal, namely, a signal indicative of occlusion in the catheter system; Catheter system consisting of an implantable catheter for implantation in a body cavity and an implantable micro-controller | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 3, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 3, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 3, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 19, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 19, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 19, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 11, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 10, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 14, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 20, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 20, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 20, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 30, 2021 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Aug 29, 2021 | ALIE | ASSIGNED TO LIE | — |
| Aug 25, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 6, 2021 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jun 4, 2021 | NWAP | NEW APPLICATION ENTERED | — |